These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 17602979)

  • 1. The safety of amiodarone in patients with heart failure.
    Torp-Pedersen C; Metra M; Spark P; Lukas MA; Moullet C; Scherhag A; Komajda M; Cleland JG; Remme W; Di Lenarda A; Swedberg K; Poole-Wilson PA;
    J Card Fail; 2007 Jun; 13(5):340-5. PubMed ID: 17602979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET.
    Swedberg K; Olsson LG; Charlesworth A; Cleland J; Hanrath P; Komajda M; Metra M; Torp-Pedersen C; Poole-Wilson P
    Eur Heart J; 2005 Jul; 26(13):1303-8. PubMed ID: 15767288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of metoprolol and carvedilol on cause-specific mortality and morbidity in patients with chronic heart failure--COMET.
    Torp-Pedersen C; Poole-Wilson PA; Swedberg K; Cleland JG; Di Lenarda A; Hanrath P; Komajda M; Lutiger B; Metra M; Remme WJ; Scherhag A; Skene A;
    Am Heart J; 2005 Feb; 149(2):370-6. PubMed ID: 15846279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of carvedilol and metoprolol on the mode of death in patients with heart failure.
    Remme WJ; Cleland JG; Erhardt L; Spark P; Torp-Pedersen C; Metra M; Komajda M; Moullet C; Lukas MA; Poole-Wilson P; Di Lenarda A; Swedberg K
    Eur J Heart Fail; 2007 Nov; 9(11):1128-35. PubMed ID: 17716943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
    Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
    J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.
    Bardy GH; Lee KL; Mark DB; Poole JE; Packer DL; Boineau R; Domanski M; Troutman C; Anderson J; Johnson G; McNulty SE; Clapp-Channing N; Davidson-Ray LD; Fraulo ES; Fishbein DP; Luceri RM; Ip JH;
    N Engl J Med; 2005 Jan; 352(3):225-37. PubMed ID: 15659722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carvedilol protects better against vascular events than metoprolol in heart failure: results from COMET.
    Remme WJ; Torp-Pedersen C; Cleland JG; Poole-Wilson PA; Metra M; Komajda M; Swedberg K; Di Lenarda A; Spark P; Scherhag A; Moullet C; Lukas MA
    J Am Coll Cardiol; 2007 Mar; 49(9):963-71. PubMed ID: 17336720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metoprolol versus amiodarone in the prevention of atrial fibrillation after cardiac surgery: a randomized trial.
    Halonen J; Loponen P; Järvinen O; Karjalainen J; Parviainen I; Halonen P; Magga J; Turpeinen A; Hippeläinen M; Hartikainen J; Hakala T
    Ann Intern Med; 2010 Dec; 153(11):703-9. PubMed ID: 21135293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sudden cardiac death risk factors in patients with heart failure treated with carvedilol.
    Nessler J; Nessler B; Kitliński M; Libionka A; Kubinyi A; Konduracka E; Piwowarska W
    Kardiol Pol; 2007 Dec; 65(12):1417-22; discussion 1423-4. PubMed ID: 18181053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sudden cardiac death in dilated cardiomyopathy -- therapeutic options.
    Grimm W; Maisch B
    Herz; 2002 Dec; 27(8):750-9. PubMed ID: 12574892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Syncope predicts the outcome of cardiomyopathy patients: analysis of the SCD-HeFT study.
    Olshansky B; Poole JE; Johnson G; Anderson J; Hellkamp AS; Packer D; Mark DB; Lee KL; Bardy GH;
    J Am Coll Cardiol; 2008 Apr; 51(13):1277-82. PubMed ID: 18371559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. THE SAFETY AND EFFICACY OF AMIODARONE AND CARVEDILOL COMBINATION IN TREATMENT OF PATIENTS WITH SEVERE CARDIAC RHYTHM DISORDERS.
    Tsetskhladze E; Khintibidze I
    Georgian Med News; 2017 Jun; (267):53-57. PubMed ID: 28726654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination therapy with carvedilol and amiodarone in patients with severe heart failure.
    Nägele H; Bohlmann M; Eck U; Petersen B; Rödiger W
    Eur J Heart Fail; 2000 Mar; 2(1):71-9. PubMed ID: 10742706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of concurrent amiodarone treatment on the tolerability and efficacy of carvedilol in patients with chronic heart failure.
    Macdonald PS; Keogh AM; Aboyoun C; Lund M; Amor R; McCaffrey D
    Heart; 1999 Nov; 82(5):589-93. PubMed ID: 10525515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutic effects of amiodarone and metoprolol on chronic heart failure complicated by ventricular arrhythmia].
    Lü HS; He BB; Huang GH
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jun; 29(6):1240-2. PubMed ID: 19726373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SPPAF), a randomized, placebo-controlled trial.
    Auer J; Weber T; Berent R; Puschmann R; Hartl P; Ng CK; Schwarz C; Lehner E; Strasser U; Lassnig E; Lamm G; Eber B;
    Am Heart J; 2004 Apr; 147(4):636-43. PubMed ID: 15077078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of thromboembolism in heart failure: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).
    Freudenberger RS; Hellkamp AS; Halperin JL; Poole J; Anderson J; Johnson G; Mark DB; Lee KL; Bardy GH;
    Circulation; 2007 May; 115(20):2637-41. PubMed ID: 17485579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Death and hospitalization in heart failure patients receiving carvedilol vs. metoprolol tartrate.
    Delea TE; Stanford R; Hagiwara M; Edelsberg JS; Oster G
    Int J Cardiol; 2005 Mar; 99(1):117-24. PubMed ID: 15721509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of amiodarone and sotalol on ventricular defibrillation threshold: the optimal pharmacological therapy in cardioverter defibrillator patients (OPTIC) trial.
    Hohnloser SH; Dorian P; Roberts R; Gent M; Israel CW; Fain E; Champagne J; Connolly SJ
    Circulation; 2006 Jul; 114(2):104-9. PubMed ID: 16818810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of carvedilol arrhythmia data in clinical trials.
    Kowey PR
    J Cardiovasc Pharmacol Ther; 2005 Jun; 10 Suppl 1():S59-68. PubMed ID: 15965573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.